TSBK (Timberland Bancorp Inc) Stock Analysis - Hedge Fund Holdings
Timberland Bancorp Inc (TSBK) is a publicly traded Financial Services sector company. As of May 21, 2026, TSBK trades at $40.55 with a market cap of $311.08M and a P/E ratio of 13.29. TSBK moved +1.05% today. Year to date, TSBK is +11.93%; over the trailing twelve months it is +29.25%. Its 52-week range spans $27.51 to $43.55. Rallies surfaces TSBK's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Who owns TSBK stock?
Hedge funds tracked by Rallies that own TSBK include Panagora Asset. The latest tracked quarter is Mar 31, 2026. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Timberland Bancorp Inc.
TSBK Key Metrics
Key financial metrics for TSBK
Metric
Value
Price
$40.55
Market Cap
$311.08M
P/E Ratio
13.29
EPS
$3.02
Dividend Yield
0.29%
52-Week High
$43.55
52-Week Low
$27.51
Volume
2
Avg Volume
0
Revenue (TTM)
$94.83M
Net Income
$24.28M
Gross Margin
0.00%
Top Hedge Funds Holding TSBK
Panagora Asset holds 30.24K shares of TSBK, changed -0.70% as of Mar 31, 2026.
Antich Breanne D sold 800 (~$32.04K) on Feb 6, 2026.
BASICH MARCI A sold 477 (~$18.84K) on Feb 5, 2026.
Fischer Jonathan Arthur sold 2.00K (~$79.00K) on Feb 5, 2026.
TSBK Analyst Consensus
TSBK analyst coverage data. Average price target: $0.00.
Common questions about TSBK
Who owns TSBK stock?
Hedge funds tracked by Rallies that own TSBK include Panagora Asset. The latest tracked quarter is Mar 31, 2026. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Timberland Bancorp Inc.
Does Rallies show 13F holders for TSBK?
Yes. Rallies tracks hedge fund and 13F ownership data for TSBK, including fund names, share counts, latest tracked quarter, and position changes when available.
Is TSBK research on Rallies investment advice?
No. Rallies provides research, data, and educational context for TSBK. It does not provide personalized investment advice.